Find in Library

<i>Mycobacterium abscessus</i> is an opportunistic pathogen that mainly colonizes and infects cystic fibrosis patients’ lungs. <i>M. abscessus</i> is naturally resistant to many antibiotics such as rifamycin, tetracyclines and β-lactams. The current therapeutic regimens are not very effective and are mostly based on repurposed drugs used against <i>Mycobacterium tuberculosis</i> infections. Thus, new approaches and novel strategies are urgently needed. This review aims to provide an overview of the latest ongoing findings to fight <i>M. abscessus</i> infections by analyzing emerging and alternative treatments, novel drug delivery strategies, and innovative molecules.